Use of biologic response modifiers for the management of ocular inflammatory conditions
Ocular inflammatory conditions can be challenging to manage due to their prolonged and complicated nature. While the mainstay treatment for most cases is oral or topical corticosteroids, it is very important that physicians know how other medications such as biologic response modifiers (biologics) c...
Main Authors: | Erick Rivera-Grana, Jay Siak, James T Rosenbaum |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2018;volume=13;issue=4;spage=259;epage=263;aulast=Rivera-Grana |
Similar Items
-
Thermography in ocular inflammation
by: Ankush A Kawali
Published: (2013-01-01) -
Thermography in ocular inflammation
by: Ankush A Kawali
Published: (2013-07-01) -
Biological therapy in refractory cases of uveitis and scleritis: An analysis of 18 cases from a tertiary eye care center from South India
by: Soumen Sadhu, et al.
Published: (2020-01-01) -
Reactive uveitis, retinal vasculitis and scleritis as ocular end-stage of Acanthamoeba keratitis: a histological study
by: Lei Shi, et al.
Published: (2019-12-01) -
Anti-infliximab antibodies and clinical response in noninfectious uveitis and scleritis patients treated with infliximab: A retrospective review
by: Cox, J.T, et al.
Published: (2022)